This American Depository Receipt (ADR) represents shares in TC Biopharm Holdings. It develops cell-based immunotherapies targeting cancer and infectious diseases.
This American Depository Receipt (ADR) represents shares in TC Biopharm Holdings. It develops cell-based immunotherapies targeting cancer and infectious diseases.